Bank of New York Mellon Corp - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 49 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 2.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$148,886
-58.8%
139,145
-0.3%
0.00%
Q2 2023$361,398
-33.2%
139,536
+5.2%
0.00%
Q1 2023$541,391
-19.2%
132,694
-0.5%
0.00%
Q4 2022$669,743
-66.0%
133,415
-11.4%
0.00%
Q3 2022$1,970,000
+17.5%
150,629
+15.2%
0.00%
Q2 2022$1,677,000
-17.0%
130,789
-1.3%
0.00%
Q1 2022$2,021,000
-11.3%
132,514
+3.0%
0.00%
Q4 2021$2,278,000
-7.6%
128,621
+9.7%
0.00%
Q3 2021$2,465,000
+23.2%
117,234
+15.6%
0.00%
Q2 2021$2,000,000
-13.7%
101,391
+27.1%
0.00%
Q1 2021$2,318,000
-8.0%
79,756
-4.1%
0.00%
-100.0%
Q4 2020$2,519,000
+86.2%
83,155
-2.2%
0.00%
Q3 2020$1,353,000
-15.6%
85,046
+4.8%
0.00%
Q2 2020$1,603,000
+57.9%
81,189
-1.3%
0.00%
Q1 2020$1,015,000
-6.5%
82,295
+40.1%
0.00%
Q4 2019$1,085,000
+214.5%
58,728
+135.5%
0.00%
Q3 2019$345,000
+96.0%
24,937
+107.7%
0.00%
Q2 2019$176,00012,0090.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,766,666$79,175,00044.14%
Ponoi II Management, LLC 1,298,908$27,303,00040.46%
Column Group LLC 15,396,116$323,626,00036.81%
Ponoi Management, LLC 1,298,908$27,303,00024.24%
Euclidean Capital LLC 832,274$17,494,0008.50%
StepStone Group LP 1,573,357$33,072,0002.14%
Octagon Capital Advisors LP 200,000$4,204,0001.04%
Redmile Group, LLC 2,505,118$52,658,0000.92%
BVF INC/IL 955,000$20,074,0000.78%
Boxer Capital, LLC 500,000$10,510,0000.37%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders